4//SEC Filing
Klausner Richard 4
Accession 0001209191-17-052159
CIK 0001594864other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 7:29 PM ET
Size
9.2 KB
Accession
0001209191-17-052159
Insider Transaction Report
Form 4
Klausner Richard
Director
Transactions
- Sale
Common Stock
2017-09-07$42.27/sh−5,449$230,321→ 783,536 total - Sale
Common Stock
2017-09-07$42.76/sh−5,214$222,940→ 778,322 total - Sale
Common Stock
2017-09-07$43.83/sh−1,337$58,605→ 776,985 total
Footnotes (4)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2017.
- [F2]This transaction was executed in multiple trades at prices ranging from $41.48 to $42.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $42.48 to $43.44. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $43.61 to $44.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Juno Therapeutics, Inc.
CIK 0001594864
Entity typeother
Related Parties
1- filerCIK 0001591178
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 7:29 PM ET
- Size
- 9.2 KB